Spring 2010
OCT is poised to turn the eye into a reliable window into MS, says Peter Calabresi.
Articles in this Issue
Brain Hemorrhage
-
Johns Hopkins Brain Injury Outcomes Services (BIOS) Division, under the direction of Dan Hanley, is leading several multicenter clinical trials in an effort to cut down on the high number of fatalities following brain hemorrhage.
Clinical Trials
-
The following clinical trials are actively recruiting patients; Epilepsy, Parkinson Disease , Multiple Sclerosis, RR MS, Primary Progressive Multiple Sclerosis, Acute Optic Neuritis, Atkins Diet , Intracerebral Hemorrhage and Intraventricular Hemorrhage, and Intracerebral Hemorrhage.
CT Scan
-
This winter, Hopkins became the first of only a handful of U.S. centers to adopt an intraoperative CT that’s so sophisticated it would be at home in a Star Wars movie.
Lesions
-
Peter Calabresi’s team is searching for ways to more accurately identify the brain lesions underlying MS—so patients can receive more refined treatment.
Pituitary Pathology
-
Pituitary tumors aren’t always easy to spot. Learn how Hopkins hopes to change this.
Pituitary Tumor
-
Neurosurgeon Alfredo Quiñones-Hinojosa and colleagues are refining a surgical technique for pituitary tumors first imagined a century ago by legendary surgeon Harvey Cushing.
White Matter
-
Lingering symptoms following traumatic brain injury seem to stem from damage to the brain’s white matter. See how Hopkins clinicians are teaming to provide a better assessment of this often overlooked damage.
View Issues Archive
Marjorie Centofanti -- Managing Editor/Writer
Melissa Hendricks -- Writer
Max Boam -- Designer
Keith Weller -- Photographer

